DENVER - TriSalus Life Sciences Inc. (Nasdaq: TLSI), a $163 million market cap company focusing on improving outcomes for patients with solid tumors, has announced the addition of healthcare veterans ...
Scientists have come up with a groundbreaking discovery in the latest study which paves the way for two men to have an ... conducted at Chinese Academy of Sciences (CAS). This marks a significant ...
Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with ... Other drugs in the class – Gilead Sciences' Zydelig (idelalisib), Bayer's Aliqopa ...